Forecasts of explosive AI progress predict that what researchers call recursive self-improvement is on the horizon. But a new study suggests that it might take a while for us to get there. The ...
13d
Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results